Astron Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 30-12-2024
- Paid Up Capital ₹ 0.20 M
as on 30-12-2024
- Company Age 19 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.60 M
as on 30-12-2024
About Astron Lifesciences
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹1.60 M.
Jasmeet Madhar, Priti Madhar, and Nirmaljit Gill serve as directors at the Company.
- CIN/LLPIN
U51397PB2005PTC028682
- Company No.
028682
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jul 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- LocationDistt. Ropar., Punjab
- Telephone
- Email Address
- Website
- Social Media
What products or services does Astron Lifesciences Private Limited offer?
Astron Lifesciences Private Limited offers a wide range of products and services, including Pharma Franchise, PCD Pharma Franchise, Vitamin & Multivitamin Injections, Methylcobalamin Injection, Antacid Drugs, Magaldrate Simethicone Oral Suspension, Pharmaceutical Syrup, Oral Suspension.
Who are the key members and board of directors at Astron Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nirmaljit Gill  | Director | 18-Jul-2005 | Current |
Jasmeet Madhar  | Director | 26-Aug-2019 | Current |
| Priti Madhar | Director | 04-Jul-2022 | Current |
Financial Performance of Astron Lifesciences.
Astron Lifesciences Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Astron Lifesciences?
In 2017, Astron Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Jammu And Kashmir Bank Limited Creation Date: 31 Mar 2015 | ₹1.00 M | Open |
The J & K Bank Ltd Creation Date: 02 May 2008 | ₹0.60 M | Open |
How Many Employees Work at Astron Lifesciences?
Unlock and access historical data on people associated with Astron Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Astron Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Astron Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
